Salcit Technologies Receives SAMD Manufacturing Licence

Salcit Technologies Receives SAMD Manufacturing Licence

Salcit Technologies has received a Class B Medical Device Licence for manufacturing and distributing their Swaasa AI Platform.

Swaasa uses machine learning models to analyse cough sounds in a patient. In combination with information about other parameters like temperature, oxygen saturation, etc., the platform can accurately assess a patient’s lung performance. With this licence, Salcit is now the first manufacturing licence holder company of Software as a Medical Device (SaMD), which works on cough.